Product Name

  • Name

    3-Chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

  • EINECS 251-301-0
  • CAS No. 32943-25-2
  • Article Data15
  • CAS DataBase
  • Density 1.197 g/cm3
  • Solubility
  • Melting Point 87 °C
  • Formula C14H12ClN
  • Boiling Point 347.1 °C at 760 mmHg
  • Molecular Weight 229.709
  • Flash Point 163.7 °C
  • Transport Information
  • Appearance
  • Safety
  • Risk Codes
  • Molecular Structure Molecular Structure of 32943-25-2 (3-Chloro-10,11-dihydro-5H-dibenzo[b,f]azepine)
  • Hazard Symbols
  • Synonyms 3-Chloro-10,11-dihydro-5H-dibenz[b,f]azepine;3-Chloroiminodibenzyl;
  • PSA 12.03000
  • LogP 4.32020

Synthetic route

3-chloro-5-(3-dimethylaminopropyl)-10,11-dihydro-5H-dibenzo(6,5)azepine
25961-11-9

3-chloro-5-(3-dimethylaminopropyl)-10,11-dihydro-5H-dibenzo(6,5)azepine

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
32943-25-2

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

Conditions
ConditionsYield
With potassium hydroxide In methanol Heating;95%
Stage #1: 3-chloro-5-(3-dimethylaminopropyl)-10,11-dihydro-5H-dibenzo(6,5)azepine With Triethoxysilane; sodium triethylborohydride In tert-butyl methyl ether at 80℃; for 6h;
Stage #2: With hydrogenchloride In tert-butyl methyl ether; water at 20℃; for 1h; Reagent/catalyst; Temperature; Concentration; chemoselective reaction;
91%
With triethyl borane; sodium hydroxide In tert-butyl methyl ether at 80℃; for 6h; Inert atmosphere; Sealed tube;86%
Multi-step reaction with 2 steps
1: potassium hydroxide; triethyl borane / tetrahydrofuran / 24 h / 100 °C / Inert atmosphere; Schlenk technique; Sealed tube
2: sodium hydroxide; water / tetrahydrofuran / 1 h / 25 °C / Inert atmosphere; Schlenk technique; Sealed tube
View Scheme
With potassium hydroxide In toluene at 85℃; for 6h;
3-chloro-5H-dibenzo[b,f]azepine
39607-90-4

3-chloro-5H-dibenzo[b,f]azepine

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
32943-25-2

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

Conditions
ConditionsYield
With methanol; magnesium at 50℃; for 1.5h;95%
3-chloro-10,11-dihydro-dibenzo[b,f]azepine-5-carbaldehyde

3-chloro-10,11-dihydro-dibenzo[b,f]azepine-5-carbaldehyde

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
32943-25-2

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

Conditions
ConditionsYield
With sodium hydroxide In dimethyl sulfoxide at 75℃; for 0.5h; Yield given;
4-chloro-2-nitrotoluene
89-59-8

4-chloro-2-nitrotoluene

copper-powder

copper-powder

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
32943-25-2

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1: N-bromosuccinimide, benzoyl peroxide / CCl4 / 28 h / Heating
2: 5 h / Heating
3: 83 percent / NaH / 1,2-dimethoxy-ethane / 2 h / Heating
4: 82 percent / H2, morpholine / 5 percent Rh/C / ethanol; methanol / 4 h / 18100.2 Torr / Ambient temperature
5: 81 percent / HCOONa / 3 h / Heating
6: K2CO3, Cu, CuBr / dimethylsulfoxide / 3 h / 160 °C
7: 5 N aq. NaOH / dimethylsulfoxide / 0.5 h / 75 °C
View Scheme
4-chloro-2-nitrobenzyl bromide
52311-59-8

4-chloro-2-nitrobenzyl bromide

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
32943-25-2

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: 5 h / Heating
2: 83 percent / NaH / 1,2-dimethoxy-ethane / 2 h / Heating
3: 82 percent / H2, morpholine / 5 percent Rh/C / ethanol; methanol / 4 h / 18100.2 Torr / Ambient temperature
4: 81 percent / HCOONa / 3 h / Heating
5: K2CO3, Cu, CuBr / dimethylsulfoxide / 3 h / 160 °C
6: 5 N aq. NaOH / dimethylsulfoxide / 0.5 h / 75 °C
View Scheme
2-[2-(2-bromo-phenyl)-ethyl]-5-chloro-phenylamine
223787-53-9

2-[2-(2-bromo-phenyl)-ethyl]-5-chloro-phenylamine

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
32943-25-2

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 81 percent / HCOONa / 3 h / Heating
2: K2CO3, Cu, CuBr / dimethylsulfoxide / 3 h / 160 °C
3: 5 N aq. NaOH / dimethylsulfoxide / 0.5 h / 75 °C
View Scheme
1-[(E)-2-(2-Bromo-phenyl)-vinyl]-4-chloro-2-nitro-benzene

1-[(E)-2-(2-Bromo-phenyl)-vinyl]-4-chloro-2-nitro-benzene

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
32943-25-2

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 82 percent / H2, morpholine / 5 percent Rh/C / ethanol; methanol / 4 h / 18100.2 Torr / Ambient temperature
2: 81 percent / HCOONa / 3 h / Heating
3: K2CO3, Cu, CuBr / dimethylsulfoxide / 3 h / 160 °C
4: 5 N aq. NaOH / dimethylsulfoxide / 0.5 h / 75 °C
View Scheme
4-chloro-2-nitrobenzylphosphonic acid diethyl ester
52311-60-1

4-chloro-2-nitrobenzylphosphonic acid diethyl ester

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
32943-25-2

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 83 percent / NaH / 1,2-dimethoxy-ethane / 2 h / Heating
2: 82 percent / H2, morpholine / 5 percent Rh/C / ethanol; methanol / 4 h / 18100.2 Torr / Ambient temperature
3: 81 percent / HCOONa / 3 h / Heating
4: K2CO3, Cu, CuBr / dimethylsulfoxide / 3 h / 160 °C
5: 5 N aq. NaOH / dimethylsulfoxide / 0.5 h / 75 °C
View Scheme
N-{2-[2-(2-bromo-phenyl)-ethyl]-5-chloro-phenyl}-formamide
223787-58-4

N-{2-[2-(2-bromo-phenyl)-ethyl]-5-chloro-phenyl}-formamide

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
32943-25-2

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: K2CO3, Cu, CuBr / dimethylsulfoxide / 3 h / 160 °C
2: 5 N aq. NaOH / dimethylsulfoxide / 0.5 h / 75 °C
View Scheme
3-amino-5-acetyl-10,11-dihydro-5H-dibenzazepine
84803-67-8

3-amino-5-acetyl-10,11-dihydro-5H-dibenzazepine

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
32943-25-2

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 85 percent / isoamyl nitrite, CuCl2 / acetonitrile / Ambient temperature
2: 95 percent / KOH / methanol / Heating
View Scheme
clomipramine hydrochloride
17321-77-6

clomipramine hydrochloride

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
32943-25-2

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

Conditions
ConditionsYield
With horseradish peroxidase type VI; dihydrogen peroxide In water at 25℃; for 11h; Enzymatic reaction;
3-chloro-5-(3-dimethylaminopropyl)-10,11-dihydro-5H-dibenzo(6,5)azepine
25961-11-9

3-chloro-5-(3-dimethylaminopropyl)-10,11-dihydro-5H-dibenzo(6,5)azepine

A

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
32943-25-2

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

B

ethanol
64-17-5

ethanol

C

C16H16ClN

C16H16ClN

Conditions
ConditionsYield
With Mo2((1)-H)2(OtBu)6; diphenylsilane In toluene at 111℃; for 25h; Inert atmosphere; Schlenk technique;
bromochlorobenzene
106-39-8

bromochlorobenzene

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
32943-25-2

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: caesium carbonate; triphenylphosphine; palladium diacetate; potassium iodide / N,N-dimethyl-formamide / 46 h / 105 °C / Schlenk technique; Inert atmosphere
2: N,N-dimethyl-formamide / 24 h / 130 °C / Schlenk technique; Inert atmosphere
3: magnesium; methanol / 1.5 h / 50 °C
View Scheme
2-bromoaniline
615-36-1

2-bromoaniline

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
32943-25-2

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: caesium carbonate; triphenylphosphine; palladium diacetate; potassium iodide / N,N-dimethyl-formamide / 46 h / 105 °C / Schlenk technique; Inert atmosphere
2: N,N-dimethyl-formamide / 24 h / 130 °C / Schlenk technique; Inert atmosphere
3: magnesium; methanol / 1.5 h / 50 °C
View Scheme
C19H16ClN

C19H16ClN

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
32943-25-2

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: N,N-dimethyl-formamide / 24 h / 130 °C / Schlenk technique; Inert atmosphere
2: magnesium; methanol / 1.5 h / 50 °C
View Scheme
C20H23BClNO2

C20H23BClNO2

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
32943-25-2

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

Conditions
ConditionsYield
With water; sodium hydroxide In tetrahydrofuran at 25℃; for 1h; Inert atmosphere; Schlenk technique; Sealed tube;0.18 g
chloropropionic acid
107-94-8

chloropropionic acid

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
32943-25-2

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

C17H17Cl2N*ClH

C17H17Cl2N*ClH

Conditions
ConditionsYield
Stage #1: chloropropionic acid With sodium tetrahydroborate In toluene at 0 - 5℃;
Stage #2: 3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine With sodium tetrahydroborate In toluene at 25 - 80℃; for 7h;
Stage #3: With hydrogenchloride In water; isopropyl alcohol
99%
3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
32943-25-2

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

3-dimethylaminopropionic acid
6300-04-5

3-dimethylaminopropionic acid

clomipramine hydrochloride
17321-77-6

clomipramine hydrochloride

Conditions
ConditionsYield
Stage #1: 3-dimethylaminopropionic acid With sodium tetrahydroborate In toluene at 0 - 5℃;
Stage #2: 3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine With sodium tetrahydroborate In toluene at 25 - 80℃; for 5h;
Stage #3: With hydrogenchloride In water; isopropyl alcohol
98%
3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
32943-25-2

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

allyl bromide
106-95-6

allyl bromide

3-chloro-5-(prop-2-enyl)-10,11-dihydro-5H-dibenzo[b,f]azepine
1425793-87-8

3-chloro-5-(prop-2-enyl)-10,11-dihydro-5H-dibenzo[b,f]azepine

Conditions
ConditionsYield
Stage #1: 3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine With sodium hydride In N,N-dimethyl-formamide; mineral oil at 20℃; for 0.333333h; Inert atmosphere;
Stage #2: allyl bromide In N,N-dimethyl-formamide; mineral oil at 20℃; for 1h; Inert atmosphere;
97%
3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
32943-25-2

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

chloroacetyl chloride
79-04-9

chloroacetyl chloride

2-chloro-1-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)ethanone
726140-60-9

2-chloro-1-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)ethanone

Conditions
ConditionsYield
In toluene at 100℃; for 1h;93%
In toluene at 100℃; for 1h;87%
In toluene for 12h; Heating;53%
In toluene Heating;
3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
32943-25-2

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

iodobenzene
591-50-4

iodobenzene

C20H16ClN

C20H16ClN

Conditions
ConditionsYield
With nickel(II) oxide; potassium tert-butylate; triphenylphosphine In tetrahydrofuran at 100℃; for 24h; Inert atmosphere; Sealed tube; Green chemistry;90%
With potassium tert-butylate; copper(II) oxide In dimethyl sulfoxide at 80℃; for 18h; Reagent/catalyst; Inert atmosphere;83%
With potassium tert-butylate; copper(II) oxide In dimethyl sulfoxide at 80℃; for 18h; Solvent; Sealed tube; Inert atmosphere;83%
bromobenzene
108-86-1

bromobenzene

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
32943-25-2

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

C20H16ClN

C20H16ClN

Conditions
ConditionsYield
With nickel(II) oxide; potassium tert-butylate; triphenylphosphine In tetrahydrofuran at 100℃; for 24h; Inert atmosphere; Sealed tube; Green chemistry;90%
With potassium tert-butylate; copper(II) oxide In dimethyl sulfoxide at 80℃; for 18h; Reagent/catalyst; Inert atmosphere;86%
With potassium tert-butylate; copper(II) oxide In dimethyl sulfoxide at 80℃; for 18h; Solvent; Sealed tube; Inert atmosphere;86%
2-bromoacetyl chloride
22118-09-8

2-bromoacetyl chloride

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
32943-25-2

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

2-bromo-1-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)ethan-1-one

2-bromo-1-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)ethan-1-one

Conditions
ConditionsYield
In toluene at 100℃; for 1h;90%
3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
32943-25-2

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

2-Bromo-m-xylene
576-22-7

2-Bromo-m-xylene

3-chloro-N-(2,6-dimethylphenyl)iminodibenzyl

3-chloro-N-(2,6-dimethylphenyl)iminodibenzyl

Conditions
ConditionsYield
With C30H43O2P*C13H12N(1-)*CH3O3S(1-)*Pd(2+); lithium hexamethyldisilazane In 1,4-dioxane at 100℃; for 16h; Inert atmosphere;89%
3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
32943-25-2

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

epichlorohydrin
106-89-8

epichlorohydrin

3-chloro-5-(oxiran-2-ylmethyl)-10,11-dihydro-5H-dibenzo[b,f]azepine
1423078-41-4

3-chloro-5-(oxiran-2-ylmethyl)-10,11-dihydro-5H-dibenzo[b,f]azepine

Conditions
ConditionsYield
Stage #1: 3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine With n-butyllithium In tetrahydrofuran; hexane at -78℃; for 0.333333h; Inert atmosphere;
Stage #2: epichlorohydrin In tetrahydrofuran; hexane at 20℃; for 23h;
88%
Stage #1: 3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine With n-butyllithium at -15 - -10℃; for 0.666667h; Inert atmosphere; Large scale;
Stage #2: epichlorohydrin at -25 - -20℃; for 1h; Inert atmosphere; Enzymatic reaction; Large scale; Further stages;
72%
3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
32943-25-2

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

2-chloropropionyl chloride
625-36-5

2-chloropropionyl chloride

3-chloro-1-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propan-1-one

3-chloro-1-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propan-1-one

Conditions
ConditionsYield
In toluene at 100℃; for 4h;87%
In toluene at 100℃; for 1h;68%
With sodium hydroxide In methanol; ethyl acetate; toluene4.0 g (57%)
3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
32943-25-2

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

methanesulfonic acid 4-(tert-butoxycarbonyl-methyl-amino)-butyl ester
99230-20-3

methanesulfonic acid 4-(tert-butoxycarbonyl-methyl-amino)-butyl ester

tert-butyl [4-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)butyl]methylcarbamate

tert-butyl [4-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)butyl]methylcarbamate

Conditions
ConditionsYield
Stage #1: 3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine With sodium hydride In N,N-dimethyl-formamide; mineral oil at 0 - 20℃; for 1h;
Stage #2: methanesulfonic acid 4-(tert-butoxycarbonyl-methyl-amino)-butyl ester In N,N-dimethyl-formamide; mineral oil at 0 - 55℃;
86%
3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
32943-25-2

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

chlorobenzene
108-90-7

chlorobenzene

C20H16ClN

C20H16ClN

Conditions
ConditionsYield
With potassium tert-butylate; copper(II) oxide In dimethyl sulfoxide at 80℃; for 18h; Inert atmosphere;85%
With potassium tert-butylate; copper(II) oxide In dimethyl sulfoxide at 80℃; for 18h; Solvent; Sealed tube; Inert atmosphere;85%
3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
32943-25-2

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

N,N-dimethyl-3-bromopropylamine
53929-74-1

N,N-dimethyl-3-bromopropylamine

Clomipramine
303-49-1

Clomipramine

Conditions
ConditionsYield
Stage #1: 3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine With sodium hydride In tetrahydrofuran at 110℃; for 2h; Glovebox; Inert atmosphere; Schlenk technique;
Stage #2: N,N-dimethyl-3-bromopropylamine In tetrahydrofuran at 110℃; for 22h; Glovebox; Inert atmosphere; Schlenk technique;
66%
3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
32943-25-2

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

2-(4-bromobutyl)isoindoline-1,3-dione
5394-18-3

2-(4-bromobutyl)isoindoline-1,3-dione

2-[4-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)butyl]-1H-isoindole-1,3(2H)-dione

2-[4-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)butyl]-1H-isoindole-1,3(2H)-dione

Conditions
ConditionsYield
Stage #1: 3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine With sodium hydride In N,N-dimethyl-formamide; mineral oil at 0℃; for 1h;
Stage #2: 2-(4-bromobutyl)isoindoline-1,3-dione In N,N-dimethyl-formamide; mineral oil at 55℃; for 4h;
58%
3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
32943-25-2

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

methanesulfonic acid 2-(tert-butoxycarbonyl-methyl-amino)propyl ester
273756-96-0

methanesulfonic acid 2-(tert-butoxycarbonyl-methyl-amino)propyl ester

tert-butyl 3-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl(methyl)carbamate

tert-butyl 3-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl(methyl)carbamate

Conditions
ConditionsYield
Stage #1: 3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine With lithium hexamethyldisilazane In tetrahydrofuran at 0 - 20℃; for 0.75h;
Stage #2: methanesulfonic acid 2-(tert-butoxycarbonyl-methyl-amino)propyl ester In tetrahydrofuran at 75℃; for 5h;
55%
sodium cyanide
773837-37-9

sodium cyanide

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
32943-25-2

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

3-cyano-iminodibenzyl
66834-19-3

3-cyano-iminodibenzyl

Conditions
ConditionsYield
With nickel(II) bromide trihydrate In 1-methyl-pyrrolidin-2-one at 200℃; for 0.5h; Microwave irradiation;33%
3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
32943-25-2

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

(1S,9aR)-1-(chloromethyl)octahydro-2H-quinolizine
34298-00-5

(1S,9aR)-1-(chloromethyl)octahydro-2H-quinolizine

3-Chloro-5-[(1R,9aR)-1-(octahydro-quinolizin-1-yl)methyl]-10,11-dihydro-5H-dibenzo[b,f]azepine; hydrochloride

3-Chloro-5-[(1R,9aR)-1-(octahydro-quinolizin-1-yl)methyl]-10,11-dihydro-5H-dibenzo[b,f]azepine; hydrochloride

Conditions
ConditionsYield
With sodium amide 1.) xylene, reflux, 1 h, 2.) xylene, reflux, 4 h; Yield given. Multistep reaction;
3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
32943-25-2

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

(1S,9aR)-1-(aminomethyl)-(octahydro-2H-quinolizine)
23506-89-0

(1S,9aR)-1-(aminomethyl)-(octahydro-2H-quinolizine)

3-Chloro-5-[(1S,9aR)-1-(octahydro-quinolizin-1-yl)methyl]-10,11-dihydro-5H-dibenzo[b,f]azepine

3-Chloro-5-[(1S,9aR)-1-(octahydro-quinolizin-1-yl)methyl]-10,11-dihydro-5H-dibenzo[b,f]azepine

Conditions
ConditionsYield
With sodium amide 1.) xylene, reflux, 1 h, 2.) xylene, reflux, 4 h; Yield given. Multistep reaction;
3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
32943-25-2

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

1-(3-chloro-10,11-dihydro-dibenzo[b,f]azepin-5-yl)-2-(octahydro-quinolizin-1-ylmethylsulfanyl)-ethanone

1-(3-chloro-10,11-dihydro-dibenzo[b,f]azepin-5-yl)-2-(octahydro-quinolizin-1-ylmethylsulfanyl)-ethanone

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: toluene / Heating
2: ethanol / Heating
View Scheme
3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
32943-25-2

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

3-chloro-5-(2-chloroethyl)-10,11-dihydro-5H-dibenz[b,f]azepine
351228-39-2

3-chloro-5-(2-chloroethyl)-10,11-dihydro-5H-dibenz[b,f]azepine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 53 percent / toluene / 12 h / Heating
2: 80 percent / NaBH4; BF3*Et2O / tetrahydrofuran / 3 h / 10 - 20 °C
View Scheme
3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
32943-25-2

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

2-(2-(3-chloro-10,11-dihydro-5H-dibenz[b,f]azepin-5-yl)ethoxy)ethanol
351228-35-8

2-(2-(3-chloro-10,11-dihydro-5H-dibenz[b,f]azepin-5-yl)ethoxy)ethanol

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: 53 percent / toluene / 12 h / Heating
2.1: 80 percent / NaBH4; BF3*Et2O / tetrahydrofuran / 3 h / 10 - 20 °C
3.1: t-BuOK / 1 h / 50 °C
3.2: 56 percent / tetrahydrofuran / 48 h / 150 °C
View Scheme
3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
32943-25-2

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

toluene-4-sulfonic acid 2-[2-(3-chloro-10,11-dihydro-dibenzo[b,f]azepin-5-yl)-ethoxy]-ethyl ester

toluene-4-sulfonic acid 2-[2-(3-chloro-10,11-dihydro-dibenzo[b,f]azepin-5-yl)-ethoxy]-ethyl ester

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: 53 percent / toluene / 12 h / Heating
2.1: 80 percent / NaBH4; BF3*Et2O / tetrahydrofuran / 3 h / 10 - 20 °C
3.1: t-BuOK / 1 h / 50 °C
3.2: 56 percent / tetrahydrofuran / 48 h / 150 °C
4.1: n-butyllithium / hexane; tetrahydrofuran / 0.25 h / 0 °C
4.2: hexane; tetrahydrofuran / 0.5 h / 20 °C
View Scheme
3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
32943-25-2

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

1-{2-[2-(3-chloro-10,11-dihydro-dibenzo[b,f]azepin-5-yl)-ethoxy]-ethyl}-piperidine-3-carboxylic acid

1-{2-[2-(3-chloro-10,11-dihydro-dibenzo[b,f]azepin-5-yl)-ethoxy]-ethyl}-piperidine-3-carboxylic acid

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1.1: 53 percent / toluene / 12 h / Heating
2.1: 80 percent / NaBH4; BF3*Et2O / tetrahydrofuran / 3 h / 10 - 20 °C
3.1: t-BuOK / 1 h / 50 °C
3.2: 56 percent / tetrahydrofuran / 48 h / 150 °C
4.1: n-butyllithium / hexane; tetrahydrofuran / 0.25 h / 0 °C
4.2: hexane; tetrahydrofuran / 0.5 h / 20 °C
5.1: K2CO3 / acetone / 120 h / 20 °C
6.1: aq. NaOH / ethanol / 20 °C
View Scheme
3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
32943-25-2

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

1-{2-[2-(3-chloro-10,11-dihydro-dibenzo[b,f]azepin-5-yl)-ethoxy]-ethyl}-piperidine-3-carboxylic acid ethyl ester

1-{2-[2-(3-chloro-10,11-dihydro-dibenzo[b,f]azepin-5-yl)-ethoxy]-ethyl}-piperidine-3-carboxylic acid ethyl ester

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: 53 percent / toluene / 12 h / Heating
2.1: 80 percent / NaBH4; BF3*Et2O / tetrahydrofuran / 3 h / 10 - 20 °C
3.1: t-BuOK / 1 h / 50 °C
3.2: 56 percent / tetrahydrofuran / 48 h / 150 °C
4.1: n-butyllithium / hexane; tetrahydrofuran / 0.25 h / 0 °C
4.2: hexane; tetrahydrofuran / 0.5 h / 20 °C
5.1: K2CO3 / acetone / 120 h / 20 °C
View Scheme

3-Chloro-10,11-dihydro-5H-dibenzo[b,f]azepine Specification

The 3-Chloroiminodibenzyl is an organic compound with the formula C14H12ClN. The systematic name of this chemical is 3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine. With the CAS registry number 32943-25-2 and EINECS 251-301-0, it is also named as 4-Chloro-2,2'-Iminodibenzyl. The product's category is API Intermediates. In addition, this chemical can be used as pharmaceutical intermediate.

The other characteristics of 3-Chloroiminodibenzyl can be summarized as: (1)ACD/LogP: 4.93; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): 4.93; (4)ACD/LogD (pH 7.4): 4.93; (5)ACD/BCF (pH 5.5): 3283.87; (6)ACD/BCF (pH 7.4): 3283.88; (7)ACD/KOC (pH 5.5): 11445.2; (8)ACD/KOC (pH 7.4): 11445.22; (9)#H bond acceptors: 1; (10)#H bond donors: 1; (11)#Freely Rotating Bonds: 0; (12)Polar Surface Area: 3.24 Å2; (13)Index of Refraction: 1.611; (14)Molar Refractivity: 66.65 cm3; (15)Molar Volume: 191.7 cm3; (16)Surface Tension: 44.5 dyne/cm; (17)Enthalpy of Vaporization: 59.14 kJ/mol; (18)Vapour Pressure: 5.5E-05 mmHg at 25°C; (19)Exact Mass: 308.235145; (20)MonoIsotopic Mass: 308.235145; (21)Topological Polar Surface Area: 60.7; (22)Heavy Atom Count: 22; (23)Complexity: 452.

People can use the following data to convert to the molecule structure. 
1. SMILES:Clc1ccc3c(c1)Nc2ccccc2CC3
2. InChI:InChI=1/C14H12ClN/c15-12-8-7-11-6-5-10-3-1-2-4-13(10)16-14(11)9-12/h1-4,7-9,16H,5-6H2
3. InChIKey:MHUXTOYYIDFXRF-UHFFFAOYAZ
4. Std. InChI:InChI=1S/C14H12ClN/c15-12-8-7-11-6-5-10-3-1-2-4-13(10)16-14(11)9-12/h1-4,7-9,16H,5-6H2 
5. Std. InChIKey:MHUXTOYYIDFXRF-UHFFFAOYSA-N

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View